Advertisement
Advertisement
iBio Unveils Promising Preclinical Data for IBIO-610
PremiumCompany AnnouncementsiBio Unveils Promising Preclinical Data for IBIO-610
15d ago
iBio announces new preclinical data on NHP study of IBIO-1610
Premium
The Fly
iBio announces new preclinical data on NHP study of IBIO-1610
15d ago
iBio price target raised to $6 from $5 at Oppenheimer
Premium
The Fly
iBio price target raised to $6 from $5 at Oppenheimer
15d ago
iBio initiated with an Outperform at Oppenheimer
PremiumThe FlyiBio initiated with an Outperform at Oppenheimer
24d ago
iBio initiated with an Outperform at Oppenheimer
Premium
The Fly
iBio initiated with an Outperform at Oppenheimer
24d ago
iBio initiated with an Outperform at Leerink
Premium
The Fly
iBio initiated with an Outperform at Leerink
28d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
iBio Announces $50 Million Public Offering Agreement
Premium
Company Announcements
iBio Announces $50 Million Public Offering Agreement
3M ago
iBio 71.54M share Spot Secondary priced at $0.70
Premium
The Fly
iBio 71.54M share Spot Secondary priced at $0.70
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100